CYPHERPUNK TECHNOLOGIES INC. Foreign Currency Transaction Gain (Loss), before Tax
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Foreign Currency Transaction Gain (Loss), before Tax of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $1.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $3.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $8.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was -$2.00K, a 133.33% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $5.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$42.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$13.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$608.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-12 | $1.00K 10-Q · filed 2026-08-12 | ||
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $11.00K derived: sum of 2 quarters · filed 2026-03-16 | $9.00K derived: sum of 3 quarters · filed 2026-08-12 | $5.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $8.00K 10-Q · filed 2025-11-12 | $6.00K derived: sum of 2 quarters · filed 2026-08-12 | $2.00K 10-Q · filed 2025-11-12 | -$22.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$2.00K 10-Q · filed 2026-08-12 | -$6.00K 10-Q · filed 2026-08-12 | -$30.00K derived: sum of 3 quarters · filed 2026-08-12 | -$38.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$4.00K 10-Q · filed 2026-05-14 | -$28.00K derived: sum of 2 quarters · filed 2026-05-14 | -$36.00K derived: sum of 3 quarters · filed 2026-05-14 | -$30.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$32.00K derived: sum of 2 quarters · filed 2026-03-16 | -$26.00K derived: sum of 3 quarters · filed 2026-03-16 | -$42.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$8.00K 10-Q · filed 2025-11-12 | -$2.00K derived: sum of 2 quarters · filed 2025-11-12 | -$18.00K 10-Q · filed 2025-11-12 | $922.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-14 | -$10.00K 10-Q · filed 2025-08-14 | $930.00K derived: sum of 3 quarters · filed 2025-08-14 | $429.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$16.00K 10-Q · filed 2025-05-13 | $924.00K derived: sum of 2 quarters · filed 2025-05-13 | $423.00K derived: sum of 3 quarters · filed 2025-05-13 | $278.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $439.00K derived: sum of 2 quarters · filed 2025-03-26 | $294.00K derived: sum of 3 quarters · filed 2025-03-26 | -$13.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | -$501.00K 10-Q · filed 2024-11-13 | -$646.00K derived: sum of 2 quarters · filed 2024-11-13 | -$953.00K 10-Q · filed 2024-11-13 | -$256.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$145.00K 10-Q · filed 2024-08-12 | -$452.00K 10-Q · filed 2024-08-12 | $245.00K derived: sum of 3 quarters · filed 2024-08-12 | -$562.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$307.00K 10-Q · filed 2024-05-13 | $390.00K derived: sum of 2 quarters · filed 2024-05-13 | -$417.00K derived: sum of 3 quarters · filed 2024-05-13 | -$1.15M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$110.00K derived: sum of 2 quarters · filed 2024-03-18 | -$843.00K derived: sum of 3 quarters · filed 2024-03-18 | -$608.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$807.00K 10-Q · filed 2023-11-13 | -$1.54M derived: sum of 2 quarters · filed 2023-11-13 | -$1.30M 10-Q · filed 2023-11-13 | -$1.27M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$733.00K 10-Q · filed 2023-08-14 | -$498.00K 10-Q · filed 2023-08-14 | -$467.00K derived: sum of 3 quarters · filed 2023-08-14 | -$727.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $235.00K 10-Q · filed 2023-05-15 | $266.00K derived: sum of 2 quarters · filed 2023-05-15 | $6.00K derived: sum of 3 quarters · filed 2023-05-15 | -$123.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$229.00K derived: sum of 2 quarters · filed 2023-03-24 | -$358.00K derived: sum of 3 quarters · filed 2023-03-24 | -$379.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | -$260.00K 10-Q · filed 2022-11-14 | -$389.00K derived: sum of 2 quarters · filed 2022-11-14 | -$410.00K 10-Q · filed 2022-11-14 | $139.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$129.00K 10-Q · filed 2022-08-12 | -$150.00K 10-Q · filed 2022-08-12 | $399.00K derived: sum of 3 quarters · filed 2022-08-12 | $636.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$21.00K 10-Q · filed 2022-05-13 | $528.00K derived: sum of 2 quarters · filed 2022-05-13 | $765.00K derived: sum of 3 quarters · filed 2022-05-13 | $1.71M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $786.00K derived: sum of 2 quarters · filed 2022-03-11 | $1.73M derived: sum of 3 quarters · filed 2022-03-11 | $738.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $237.00K 10-Q · filed 2021-11-12 | $1.18M derived: sum of 2 quarters · filed 2021-11-12 | $189.00K 10-Q · filed 2021-11-12 | $429.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $943.00K 10-Q · filed 2021-08-13 | -$48.00K 10-Q · filed 2021-08-13 | $192.00K derived: sum of 3 quarters · filed 2021-08-13 | $112.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$991.00K 10-Q · filed 2021-05-14 | -$751.00K derived: sum of 2 quarters · filed 2021-05-14 | -$831.00K derived: sum of 3 quarters · filed 2021-05-14 | -$907.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $160.00K derived: sum of 2 quarters · filed 2021-03-12 | $84.00K derived: sum of 3 quarters · filed 2021-03-12 | $126.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$80.00K 10-Q · filed 2020-11-12 | -$156.00K derived: sum of 2 quarters · filed 2020-11-12 | -$114.00K 10-Q · filed 2020-11-12 | -$334.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$76.00K 10-Q · filed 2020-08-13 | -$34.00K 10-Q · filed 2020-08-13 | -$254.00K derived: sum of 3 quarters · filed 2020-08-13 | -$503.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $42.00K 10-Q · filed 2020-05-14 | -$178.00K derived: sum of 2 quarters · filed 2020-05-14 | -$427.00K derived: sum of 3 quarters · filed 2020-05-14 | -$649.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$469.00K derived: sum of 2 quarters · filed 2020-03-16 | -$691.00K derived: sum of 3 quarters · filed 2020-03-16 | -$835.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | -$249.00K 10-Q · filed 2019-11-14 | -$471.00K derived: sum of 2 quarters · filed 2019-11-14 | -$615.00K 10-Q · filed 2019-11-14 | -$679.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$222.00K 10-Q · filed 2019-08-09 | -$366.00K 10-Q · filed 2019-08-09 | -$430.00K derived: sum of 3 quarters · filed 2019-08-09 | $357.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$144.00K 10-Q · filed 2019-05-15 | -$208.00K derived: sum of 2 quarters · filed 2019-05-15 | $579.00K derived: sum of 3 quarters · filed 2019-05-15 | $147.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $723.00K derived: sum of 2 quarters · filed 2019-04-01 | $291.00K derived: sum of 3 quarters · filed 2019-04-01 | $759.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $787.00K 10-Q · filed 2018-11-09 | $355.00K derived: sum of 2 quarters · filed 2018-11-09 | $823.00K 10-Q · filed 2018-11-09 | $422.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$432.00K 10-Q · filed 2018-08-08 | $36.00K 10-Q · filed 2018-08-08 | -$365.00K derived: sum of 3 quarters · filed 2018-08-08 | -$232.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $468.00K 10-Q/A · filed 2018-08-08 | $67.00K derived: sum of 2 quarters · filed 2018-08-08 | $200.00K derived: sum of 3 quarters · filed 2018-08-08 | $142.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2016-12-31 | -$401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$268.00K derived: sum of 2 quarters · filed 2018-02-23 | -$326.00K derived: sum of 3 quarters · filed 2018-02-23 | -$217.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | $133.00K 10-Q · filed 2017-11-13 | $75.00K derived: sum of 2 quarters · filed 2017-11-13 | $184.00K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$58.00K 10-Q · filed 2017-08-11 | $51.00K 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $109.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |